Health Headlines: From Cyprus Livestock Controls to Novo's Market Shakeup
Published on: Feb. 25, 2026, 2:29 a.m. | Source: Devdiscourse
Multiple health-oriented developments are in the spotlight as Cyprus grapples with an outbreak of foot-and-mouth disease, leading to stringent livestock controls. Meanwhile, collaborations and challenges shake the pharmaceutical world, such as Frontier Biotechnologies' $1 billion deal with GSK and Novo Nordisk's market adjustments highlighting a vibrant yet volatile health sector landscape.
